Iovance Biotherapeutics
IOVA
#3883
Rank
โ‚น295.83 B
Marketcap
โ‚น639.42
Share price
-5.61%
Change (1 day)
219.00%
Change (1 year)

Market capitalization of Iovance Biotherapeutics (IOVA)

Market cap: โ‚น295.83 Billion

As of November 2026 Iovance Biotherapeutics has a market cap of โ‚น295.83 Billion. This makes Iovance Biotherapeutics the world's 3883th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Iovance Biotherapeutics from 2010 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น295.83 B193.04%
2025โ‚น100.95 B-47.9%
2024โ‚น193.78 B11.88%
2023โ‚น173.20 B107.58%
2022โ‚น83.44 B-62.57%
2021โ‚น222.93 B-55.21%
2020โ‚น497.77 B99.49%
2019โ‚น249.52 B226.72%
2018โ‚น76.37 B105.85%
2017โ‚น37.10 B26.29%
2016โ‚น29.37 B17.95%
2015โ‚น24.90 B47.95%
2014โ‚น16.83 B29.6%
2013โ‚น12.98 B1223.59%
2012โ‚น0.98 B-76.52%
2011โ‚น4.17 B5.53%
2010โ‚น3.95 B

End of Day market cap according to different sources

On Nov 20th, 2026 the market cap of Iovance Biotherapeutics was reported to be:

โ‚น295.83 Billion
by Nasdaq info icon info icon
โ‚น295.83 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Nymox Pharmaceutical
NYMX
โ‚น1.69 B-99.43% Bahamas
NRC Health
NRC
โ‚น49.47 B-83.27%๐Ÿ‡บ๐Ÿ‡ธ USA